THERAPEUTICSMD INC - COM (TXMD)

CUSIP: 88338N107

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / COM
Total 13F shares
164,535,449
Share change
+8,786,158
Total reported value
$866,656,619
Put/Call ratio
223%
Price per share
$5.29
Number of holders
132
Value change
+$45,414,189
Number of buys
68
Number of sells
47

Quarterly Holders Quick Answers

What is CUSIP 88338N107?
CUSIP 88338N107 identifies TXMD - THERAPEUTICSMD INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAPEUTICSMD INC - COM (TXMD) as of Q3 2017

As of 30 Sep 2017, THERAPEUTICSMD INC - COM (TXMD) was held by 132 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 164,535,449 shares. The largest 10 holders included FMR LLC, Bank of New York Mellon Corp, JPMORGAN CHASE & CO, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., VANGUARD GROUP INC, FRANKLIN RESOURCES INC, STATE STREET CORP, Voya Investment Management LLC, and GILDER GAGNON HOWE & CO LLC. This page lists 132 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.